AIMS: Increased heart rate (HR) is a predictor of all-cause and cardiovascular (CV) mortality. We tested which measure of HR had the strongest prognostic value in a population with no apparent heart disease. METHODS AND RESULTS: Six hundred and fifty-three men and women between the age of 55 and 75 years were included in the Copenhagen Holter Study and underwent 48 h ambulatory electrocardiographic (ECG) monitoring. Resting HR was measured after at least 10 min of rest. Twenty-four-hour HR was derived from the mean time between normal-to-normal RR intervals (MEANNN). Night-time HR was derived from a 15 min sequence between 2:00 and 2:15 a.m. The median follow-up time was 76 months, and an adverse outcome was defined as all-cause mortality and the combined endpoint of CV death, acute myocardial infarction (AMI), and revascularization. All three measures of HR were significantly associated with all-cause mortality, also after adjustment for conventional risk factors. We found an association between all three measures of HR and CV events in analyses adjusted for sex and age. However, when adjusting for CV risk factors, the association with resting HR and 24 h HR disappeared. In a fully adjusted model, only night-time HR remained in the model, hazard ratio = 1.17 (1.05-1.30), P = 0.005. CONCLUSION: In middle-aged subjects with no apparent heart disease, all measures of increased HR were associated with increased mortality and CV risk. However, night-time HR was the only parameter with prognostic importance after multivariable adjustment.
AIMS: Increased heart rate (HR) is a predictor of all-cause and cardiovascular (CV) mortality. We tested which measure of HR had the strongest prognostic value in a population with no apparent heart disease. METHODS AND RESULTS: Six hundred and fifty-three men and women between the age of 55 and 75 years were included in the Copenhagen Holter Study and underwent 48 h ambulatory electrocardiographic (ECG) monitoring. Resting HR was measured after at least 10 min of rest. Twenty-four-hour HR was derived from the mean time between normal-to-normal RR intervals (MEANNN). Night-time HR was derived from a 15 min sequence between 2:00 and 2:15 a.m. The median follow-up time was 76 months, and an adverse outcome was defined as all-cause mortality and the combined endpoint of CV death, acute myocardial infarction (AMI), and revascularization. All three measures of HR were significantly associated with all-cause mortality, also after adjustment for conventional risk factors. We found an association between all three measures of HR and CV events in analyses adjusted for sex and age. However, when adjusting for CV risk factors, the association with resting HR and 24 h HR disappeared. In a fully adjusted model, only night-time HR remained in the model, hazard ratio = 1.17 (1.05-1.30), P = 0.005. CONCLUSION: In middle-aged subjects with no apparent heart disease, all measures of increased HR were associated with increased mortality and CV risk. However, night-time HR was the only parameter with prognostic importance after multivariable adjustment.
Authors: Kathleen F Kerr; Christy L Avery; Henry J Lin; Laura M Raffield; Qian S Zhang; Brian L Browning; Sharon R Browning; Matthew P Conomos; Stephanie M Gogarten; Cathy C Laurie; Tamar Sofer; Timothy A Thornton; Chancellor Hohensee; Rebecca D Jackson; Charles Kooperberg; Yun Li; Raúl Méndez-Giráldez; Marco V Perez; Ulrike Peters; Alexander P Reiner; Zhu-Ming Zhang; Jie Yao; Nona Sotoodehnia; Kent D Taylor; Xiuqing Guo; Leslie A Lange; Elsayed Z Soliman; James G Wilson; Jerome I Rotter; Susan R Heckbert; Deepti Jain; Eric A Whitsel Journal: Heart Rhythm Date: 2017-06-10 Impact factor: 6.343
Authors: Koki Nakanishi; Zhezhen Jin; Shunichi Homma; Mitchell S V Elkind; Tatjana Rundek; Seitetz C Lee; Aylin Tugcu; Mitsuhiro Yoshita; Charles DeCarli; Clinton B Wright; Ralph L Sacco; Marco R Di Tullio Journal: Stroke Date: 2017-12-28 Impact factor: 7.914
Authors: Bríain O Hartaigh; Martin Gaksch; Katharina Kienreich; Martin R Grübler; Nicolas Verheyen; Winfried März; Andreas Tomaschitz; Thomas M Gill; Stefan Pilz Journal: J Clin Hypertens (Greenwich) Date: 2014-09-30 Impact factor: 3.738
Authors: Mi-Sun Lee; Ki-Do Eum; Shona C Fang; Ema G Rodrigues; Geoffrey A Modest; David C Christiani Journal: Int J Cardiol Date: 2014-07-11 Impact factor: 4.164